Intuitive Surgical Inc (NASDAQ:ISRG) does about 2.23M shares in volume on a normal day but saw 2091272 shares change hands in the recent trading day. The company now has a market cap of 197.97B USD. Its current market price is $552.34, marking a decrease of -0.61% compared to the previous close of $555.75. The 52 week high reached by this stock is $616.00 whilst the lowest price level in 52 weeks is $396.48. The script in recent trading has seen the stock touch a high of $650 and a low of $560.
17 analysts observing the Intuitive Surgical Inc (ISRG) stock have set the 12-month price targets for the company’s shares at between $560 and $650. The consensus objective for the share price is $579.83, suggesting that the stock has a potential upside of 4.74% over the period. The median price target is 8.33% away from the current levels at $602.5.
FactSet Research has provided data showing that 17 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 13 analysts have rated it as a buy and 4 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 02, 2024 when Morgan Stanley upgraded the stock to “Overweight” and issued a price target of between $522 and $650. Redburn Atlantic also upgraded the stock to “Buy” from Neutral on August 02, 2024 at a price target of $380-$510. Citigroup reiterated its price target at $462-$512.
The current price level is 0.64%, 6.91%, and 5.42% away from its SMA20, SMA50, and SMA200 respectively, with the ISRG price moving above the 50-day SMA on current market day. Intuitive Surgical Inc (ISRG) stock is up 1.78% over the week and 7.08% over the past month. Its price is 5.82% year-to-date and 37.73% over the past year.
Its 12-month price target is $602.5. To reach the target analysts have set, the stock logically needs to grow 4.74 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $560, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $650.
Outstanding shares total 358.40M with insiders holding 0.52% of the shares and institutional holders owning 88.98% of the company’s common stock. The company has a return on investment of 14.47% and return on equity of 15.94%. The price to earnings ratio (P/E ratio) amounts to 81.02 while the forward price to earnings ratio is 61.07. The beta has a value of 1.67. Price to book ratio is 11.57 and price to sales ratio is 22.72.
